Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients
Clinical trial NCT04834856 · COMPLETED
Trial details
- NCT number
- NCT04834856
- Sponsor
- Molecular Partners AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2021-08-20
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.